Novartis Oncology is investigating the PI3K/AKT/mTOR pathway to understand and treat advanced breast cancer.

ResourcesVideosBreast cancerCancersInternal medicineMedical oncologyMedicineMedicine, Diagnosis, and TherapeuticsSystemic conditionsNovartis
Previous articleAACR Special: Brisk Traffic at AACR Job Fair; Sunday Sessions Preview
Next articleAACR Special: Opening Plenary Session Sets Bar of Excellence for Entire Conference